Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Brenton

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|August 9, 2003
Predictive cancer genomics--what do we need?James D Brenton, Carlos Caldas
Future Oncology (London, England)|May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinomaIoannis Gounaris, James D Brenton
Nature Medicine|July 15, 2005
Sizing up miRNAs as cancer genesCarlos Caldas, James D Brenton
Nature|March 8, 2013
Stem cells: Anatomy of an ovarian cancerJames D Brenton, John Stingl
Breast Cancer Research : BCR|July 1, 2005
Microarrays and breast cancer clinical studies: forgetting what we have not yet learntAhmed Ashour Ahmed, James D Brenton
The Lancet. Oncology|July 12, 2011
Evolution of platinum resistance in high-grade serous ovarian cancerSusanna L Cooke, James D Brenton
Trends in Genetics : TIG|August 2, 2016
Sequencing Structural Variants in Cancer for Precision TherapeuticsGeoff Macintyre, Bauke Ylstra, James D Brenton
The Journal of Pathology. Clinical Research|July 14, 2018
You won't believe this old test … that does cheap single-cell mutation detectionMartin Köbel, Michael S Anglesio, James D Brenton
Molecular Cancer|May 30, 2012
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cellsDavid A Tumbarello, Jillian Temple, James D Brenton
The Journal of Pathology|September 8, 2011
Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?Ioannis Gounaris, D Stephen Charnock-Jones, James D Brenton
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|August 9, 2003
Predictive cancer genomics--what do we need?James D Brenton, Carlos Caldas
Future Oncology (London, England)|May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinomaIoannis Gounaris, James D Brenton
Nature Medicine|July 15, 2005
Sizing up miRNAs as cancer genesCarlos Caldas, James D Brenton
Nature|March 8, 2013
Stem cells: Anatomy of an ovarian cancerJames D Brenton, John Stingl
Breast Cancer Research : BCR|July 1, 2005
Microarrays and breast cancer clinical studies: forgetting what we have not yet learntAhmed Ashour Ahmed, James D Brenton
The Lancet. Oncology|July 12, 2011
Evolution of platinum resistance in high-grade serous ovarian cancerSusanna L Cooke, James D Brenton
Trends in Genetics : TIG|August 2, 2016
Sequencing Structural Variants in Cancer for Precision TherapeuticsGeoff Macintyre, Bauke Ylstra, James D Brenton
The Journal of Pathology. Clinical Research|July 14, 2018
You won't believe this old test … that does cheap single-cell mutation detectionMartin Köbel, Michael S Anglesio, James D Brenton
Molecular Cancer|May 30, 2012
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cellsDavid A Tumbarello, Jillian Temple, James D Brenton
The Journal of Pathology|September 8, 2011
Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?Ioannis Gounaris, D Stephen Charnock-Jones, James D Brenton
Pageof 20